Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Source Tissue

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search
Show additional data
do not include text mining results
include AMENDA results (Automatic Mining of Enzyme Data)

Search term: breast cancer cell

Results 1 - 100 of 309 > >>
download as CSV
download all results as CSV
EC Number Recommended Name Source Tissue Commentary Reference
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.1cathepsin B breast cancer cell - 36625, 753138
Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.8glycerol-3-phosphate dehydrogenase (NAD+) breast cancer cell - 287331
Display the word mapDisplay the reaction diagram Show all sequences 1.14.11.16peptide-aspartate beta-dioxygenase breast cancer cell highly expressed 439254
Display the word mapDisplay the reaction diagram Show all sequences 2.7.10.2non-specific protein-tyrosine kinase breast cancer cell breast cancer 490443
Display the word mapDisplay the reaction diagram Show all sequences 2.7.10.2non-specific protein-tyrosine kinase breast cancer cell breast carcinomas 490594
Display the word mapDisplay the reaction diagram Show all sequences 2.7.10.2non-specific protein-tyrosine kinase breast cancer cell breast tumours 490596
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.59caspase-6 breast cancer cell - 647467
Display the word mapDisplay the reaction diagram Show all sequences 3.1.6.2steryl-sulfatase breast cancer cell expression of STS mRNA and STS activity are increased in malignant breast tissues compared with that in non-malignant tissues 656640
Show all pathways known for 1.1.1.145Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.1453beta-hydroxy-DELTA5-steroid dehydrogenase breast cancer cell - 656788, 763397
Display the word mapDisplay the reaction diagram Show all sequences 2.5.1.60protein geranylgeranyltransferase type II breast cancer cell - 658377
Display the word mapDisplay the reaction diagram Show all sequences 2.1.1.6catechol O-methyltransferase breast cancer cell - 658443, 702678
Display the word mapDisplay the reaction diagram Show all sequences 1.11.1.12phospholipid-hydroperoxide glutathione peroxidase breast cancer cell - 659398
Display the word mapDisplay the reaction diagram Show all sequences 2.7.10.2non-specific protein-tyrosine kinase breast cancer cell - 490442, 490457, 490469, 661457, 662172, 662174, 676266, 691526
Display the word mapDisplay the reaction diagram Show all sequences 2.7.10.1receptor protein-tyrosine kinase breast cancer cell overexpression of Her2-receptor 661551
Show all pathways known for 1.1.1.145Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.1453beta-hydroxy-DELTA5-steroid dehydrogenase breast cancer cell isozyme 3beta-HSD1 662371
Display the word mapDisplay the reaction diagram Show all sequences 2.7.10.1receptor protein-tyrosine kinase breast cancer cell overexpression of EGFR-TK 662724
Display the word mapDisplay the reaction diagram Show all sequences 2.8.2.29[heparan sulfate]-glucosamine 3-sulfotransferase 2 breast cancer cell - 662996, 761128
Display the word mapDisplay the reaction diagram Show all sequences 2.7.11.17Ca2+/calmodulin-dependent protein kinase breast cancer cell differential expression of CaM-KI and CaM-KII in cell lines MCF-7 and MCF-10A 664506
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.117stratum corneum chymotryptic enzyme breast cancer cell enzyme expression analysis in 155 patients, overview 664622
Display the word mapDisplay the reaction diagram Show all sequences 2.7.11.17Ca2+/calmodulin-dependent protein kinase breast cancer cell - 664865
Display the word mapDisplay the reaction diagram Show all sequences 2.7.11.22cyclin-dependent kinase breast cancer cell - 491470, 665497, 681873, 723656
Display the word mapDisplay the reaction diagram Show all sequences 2.7.11.25mitogen-activated protein kinase kinase kinase breast cancer cell high expression level of MEKK3 665600
Display the word mapDisplay the reaction diagram Show all sequences 2.7.11.24mitogen-activated protein kinase breast cancer cell - 665638
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B41kallikrein 10 breast cancer cell downregulation due to hypermethylation of exon 3 667874
Display the word mapDisplay the reaction diagram Show all sequences 3.6.5.2small monomeric GTPase breast cancer cell mRNA levels of RasL10B are down-regulated in all breast cancer cells tested (HBL100, MCF7, MDA-MB-468, MDA-MB-231 and MDA-MB-435. RasL10B) is a member of ras superfamily with tumor suppressor potential 668060
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.41cathepsin F breast cancer cell - 668085
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B45kallikrein 14 breast cancer cell KLK14 expression significantly higher compared to normal breast tissues 668103
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.26cancer procoagulant breast cancer cell - 668137
Display the word mapDisplay the reaction diagram Show all sequences 3.4.24.B3matrix metalloproteinase-11 breast cancer cell cancer cell-adipocyte interaction/crosstalk during the initial steps of cancer cell invasion 668150
Show all pathways known for 1.1.1.141Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.14115-hydroxyprostaglandin dehydrogenase (NAD+) breast cancer cell expression of the enzyme and the estrogen receptor is correlated 668162
Show all pathways known for 3.5.4.4Display the word mapDisplay the reaction diagram Show all sequences 3.5.4.4adenosine deaminase breast cancer cell the activity of isozyme ADA2 is increased 668272
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.3gastricsin breast cancer cell - 668809
Show all pathways known for 3.5.1.2Display the word mapDisplay the reaction diagram Show all sequences 3.5.1.2glutaminase breast cancer cell - 670391, 694485
Display the word mapDisplay the reaction diagram Show all sequences 3.4.24.B10ADAM12 endopeptidase breast cancer cell - 670445, 719935, 754703, 754704, 755485
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B39stratum corneum tryptic enzyme breast cancer cell no expression 670978
Show all pathways known for 2.7.1.91Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.91sphingosine kinase breast cancer cell - 671356
Show all pathways known for 1.14.15.18Display the word mapDisplay the reaction diagram Show all sequences 1.14.15.18calcidiol 1-monooxygenase breast cancer cell - 671357, 695621
Show all pathways known for 2.7.1.32Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.32choline kinase breast cancer cell - 671362, 672898, 723311, 759595, 760183
Show all pathways known for 1.14.15.18Display the word mapDisplay the reaction diagram Show all sequences 1.14.15.18calcidiol 1-monooxygenase breast cancer cell the enzyme expression is reduced in breast cancer cell specimen compared to healthy breast tissue 672857
Show all pathways known for 6.3.2.2Display the word mapDisplay the reaction diagram Show all sequences 6.3.2.2glutamate-cysteine ligase breast cancer cell treatment of human breast cancer cells with 2-deoxy-D-glucose causes metabolic oxidative stress that is accompanied by increases in steady-state levels of glutamate cysteine ligase mRNA, glutamate cysteine ligase activity and glutathione content 672904
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B28fibroblast activation protein alpha subunit breast cancer cell - 672907
Show all pathways known for 6.4.1.2Display the word mapDisplay the reaction diagram Show all sequences 6.4.1.2acetyl-CoA carboxylase breast cancer cell - 672908, 675919
Display the word mapDisplay the reaction diagram Show all sequences 2.7.10.2non-specific protein-tyrosine kinase breast cancer cell PYK2 673223
Display the word mapDisplay the reaction diagram Show all sequences 1.14.13.8flavin-containing monooxygenase breast cancer cell - 673313
Show all pathways known for 2.4.2.3Display the word mapDisplay the reaction diagram Show all sequences 2.4.2.3uridine phosphorylase breast cancer cell negative correlation between UPase expression and the clinical outcome of breast cancer 673810
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.135phosphatidylcholine-retinol O-acyltransferase breast cancer cell neoplastic and adjacent, non-neoplastic glandular breast tissue specimens from human patients, expression analysis, reduced enzyme expression, LRAT protein progressively decreases with a reduction in the degree of tumor differentiation in invasive breast carcinomas, overview 674069
Display the word mapDisplay the reaction diagram Show all sequences 2.8.2.4estrone sulfotransferase breast cancer cell invasive, postmenopausal women 674994
Display the word mapDisplay the reaction diagram Show all sequences 2.8.2.4estrone sulfotransferase breast cancer cell preinvasive and invasive cancer cells 674994
Show all pathways known for 1.1.1.213Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.2133alpha-hydroxysteroid 3-dehydrogenase (Re-specific) breast cancer cell - 675678
Show all pathways known for 1.2.1.31Display the word mapDisplay the reaction diagram Show all sequences 1.2.1.31L-aminoadipate-semialdehyde dehydrogenase breast cancer cell - 675897
Show all pathways known for 1.8.1.9Display the word mapDisplay the reaction diagram Show all sequences 1.8.1.9thioredoxin-disulfide reductase breast cancer cell - 675915
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.5arylamine N-acetyltransferase breast cancer cell patients with ductal carcinoma 676155
Display the word mapDisplay the reaction diagram Show all sequences 2.7.11.10IkappaB kinase breast cancer cell - 676886
Show all pathways known for 1.13.11.33Display the word mapDisplay the reaction diagram Show all sequences 1.13.11.33arachidonate 15-lipoxygenase breast cancer cell - 676925
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.45N-acetylneuraminate 7-O(or 9-O)-acetyltransferase breast cancer cell - 677235
Display the word mapDisplay the reaction diagram Show all sequences 3.4.14.9tripeptidyl-peptidase I breast cancer cell - 678513
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.35tissue kallikrein breast cancer cell - 678522, 752895
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B41kallikrein 10 breast cancer cell - 678524, 678530, 679256
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B25PACE4 proprotein convertase breast cancer cell - 679039
Display the word mapDisplay the reaction diagram Show all sequences 3.4.19.12ubiquitinyl hydrolase 1 breast cancer cell UCH-L3 mRNA level is significantly upregulated and UHCL1 mRNA level also show a non-significant increase in breast cancer tissue compared to adjacent normal breast tissue. Both UCH-L1 and UCH-L3 mRNA levels are significantly higher in high histological grade tumors than in low histological grade tumors. UCH-L1 mRNA level in tumors is approximately 10 times higher than that of UCH-L3 679040
Show all pathways known for 3.1.3.2Display the word mapDisplay the reaction diagram Show all sequences 3.1.3.2acid phosphatase breast cancer cell - 679089
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B43kallikrein 12 breast cancer cell - 679276
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.59caspase-6 breast cancer cell invasive operable pT1 and pT2 ductal breast carcinoma are analysed of 210 patients: caspase-6 is overexpressed in 52.9% 680072
Show all pathways known for 5.1.99.4Display the word mapDisplay the reaction diagram Show all sequences 5.1.99.4alpha-methylacyl-CoA racemase breast cancer cell - 681814, 727322
Display the word mapDisplay the reaction diagram Show all sequences 2.7.12.2mitogen-activated protein kinase kinase breast cancer cell impaired expression of MKK4 682214
Show all pathways known for 3.1.3.5Display the word mapDisplay the reaction diagram Show all sequences 3.1.3.55'-nucleotidase breast cancer cell - 682217, 691078, 693298, 750845
Display the word mapDisplay the reaction diagram Show all sequences 3.1.6.2steryl-sulfatase breast cancer cell - 682219, 706776
Show all pathways known for 2.7.2.3Display the word mapDisplay the reaction diagram Show all sequences 2.7.2.3phosphoglycerate kinase breast cancer cell moderate PGK1 expression 682792
Show all pathways known for 4.1.1.17Display the word mapDisplay the reaction diagram Show all sequences 4.1.1.17ornithine decarboxylase breast cancer cell - 682982, 695299
Display the word mapDisplay the reaction diagram Show all sequences 3.4.24.23matrilysin breast cancer cell early stage primary cancers, MMP-7 correlates with breast cancer development, overexpression of MMP-7 and ErbB4, overview 683331
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.109matriptase breast cancer cell - 683364, 683489, 683492, 683494, 683763, 683893, 695463, 717902
Show all pathways known for 3.4.19.9Display the word mapDisplay the reaction diagram Show all sequences 3.4.19.9folate gamma-glutamyl hydrolase breast cancer cell - 683368
Display the word mapDisplay the reaction diagram Show all sequences 3.4.13.9Xaa-Pro dipeptidase breast cancer cell breast cancer tissue shows high enzyme activity, reduced collagen content and decreased expression of beta1-integrins 683557
Display the word mapDisplay the reaction diagram Show all sequences 3.4.24.56insulysin breast cancer cell - 683571
Show all pathways known for 2.4.2.4Display the word mapDisplay the reaction diagram Show all sequences 2.4.2.4thymidine phosphorylase breast cancer cell - 684460, 684466, 686140, 688302, 705495
Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.6217beta-estradiol 17-dehydrogenase breast cancer cell - 685545, 711649, 713021, 726302, 740542, 740839, 740849, 761756, 761900
Display the word mapDisplay the reaction diagram Show all sequences 2.3.2.13protein-glutamine gamma-glutamyltransferase breast cancer cell MDA-MB-231 (doxorubicin resistant) human breast cancer cell 685934
Display the word mapDisplay the reaction diagram Show all sequences 1.4.3.13protein-lysine 6-oxidase breast cancer cell lymph node-negative breast adenocarcinoma cell 685957
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.137phosphatidylinositol 3-kinase breast cancer cell ER-positive breast cancer cells (UMB-1Ca) are grown as tumors in ovariectomized athymic nude mice 686138
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.5arylamine N-acetyltransferase breast cancer cell NAT1 is overexpressed in estrogen receptor-positive breast cancer 686256
Display the word mapDisplay the reaction diagram Show all sequences 1.3.1.1dihydropyrimidine dehydrogenase (NAD+) breast cancer cell - 686604, 688302, 689367
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.106hepsin breast cancer cell upregulation of hepsin mRNA in estrogen receptor alpha-positive breast tumors compared with estrogen receptor alpha-negative breast tumors 686903
Display the word mapDisplay the reaction diagram Show all sequences 1.4.3.13protein-lysine 6-oxidase breast cancer cell - 687920, 713156
Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.6217beta-estradiol 17-dehydrogenase breast cancer cell 17beta-HSD1 is overexpressed in many breast tumors 688272
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.5arylamine N-acetyltransferase breast cancer cell methylation status and the transcriptional activity of NAT1 in breast cancer tissues: methylation of NAT1 gene is identified in 39 of the breast carcinomas (54.2%), 23 normal (76.7%) and 25 benign breast tissue samples (80.6%). Breast cancer tissues show significantly lower methylation rates of the NAT1 promoters than the normal and benign tissues. Cancer tissues show lower methylation density rates than normal and benign breast tissues. Tissues that show aberrant methylation of NAT1 show significantly less mRNA expression compared with the unmethylated cases. 20 cancers from the methylated group show positive staining for the estrogen receptor (ER) (51.3%), while 72.7% from the unmethylated group stain positive 689296
Display the word mapDisplay the reaction diagram Show all sequences 2.7.10.1receptor protein-tyrosine kinase breast cancer cell - 490103, 672895, 690303, 690447, 701713
Display the word mapDisplay the reaction diagram Show all sequences 2.7.10.1receptor protein-tyrosine kinase breast cancer cell overexpression of Ron 690303
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.B41kallikrein 10 breast cancer cell KLK10 is not methylated in normal breast tissues and fibroadenomas while it is in 5 of 10 breast tumors and in 1 of 10 matching normal tissues 690443
Show all pathways known for 3.1.3.11Display the word mapDisplay the reaction diagram Show all sequences 3.1.3.11fructose-bisphosphatase breast cancer cell - 690771
Display the word mapDisplay the reaction diagram Show all sequences 3.1.3.16protein-serine/threonine phosphatase breast cancer cell elevated levels of PP5 protein occur in human breast cancer and suggest that PP5 over-expression may aid tumor progression 691077
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.117stratum corneum chymotryptic enzyme breast cancer cell in contrast to the expression in ovarian cancer, high expression of KLK 7 is strongly associated with good prognosis in breast cancer patients 691153
Show all pathways known for 5.3.3.8Display the word mapDisplay the reaction diagram Show all sequences 5.3.3.8DELTA3-DELTA2-enoyl-CoA isomerase breast cancer cell - 691485
Display the word mapDisplay the reaction diagram Show all sequences 3.4.24.B4matrix metalloproteinase-13 breast cancer cell - 691486, 712933
Display the word mapDisplay the reaction diagram Show all sequences 5.6.2.2DNA topoisomerase (ATP-hydrolysing) breast cancer cell with a mutation in gene BRCA1 691488
Show all pathways known for 4.1.1.22Display the word mapDisplay the reaction diagram Show all sequences 4.1.1.22histidine decarboxylase breast cancer cell HDC expression is significantly increased in carcinoma cells 691585
Display the word mapDisplay the reaction diagram Show all sequences 3.1.26.5ribonuclease P breast cancer cell - 691597
Display the word mapDisplay the reaction diagram Show all sequences 2.8.2.4estrone sulfotransferase breast cancer cell - 671361, 676931, 691170, 691624, 693848, 701710, 701711, 761874
Display the word mapDisplay the reaction diagram Show all sequences 2.7.7.49RNA-directed DNA polymerase breast cancer cell - 692248
Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.166heparanase breast cancer cell express high levels of endogenous heparanase-1 693320
Display the word mapDisplay the reaction diagram Show all sequences 2.7.10.1receptor protein-tyrosine kinase breast cancer cell EphA2 forms a complex with ErbB2, resulting in enhanced activation of Ras-MAPK signaling and RhoA GTPase 693355
Results 1 - 100 of 309 > >>
download as CSV
download all results as CSV